Search Results - "Harrison, Prof. Stephen A."

FRI-355-Elafibranor, a drug candidate for first line NASH monotherapy and a universal backbone for drug combination treatment by Legry, Vanessa, Descamps, Emeline, Noel, Benoit, Foucart, Corinne, Degallaix, Nathalie, Belanger, Carole, Hum, Dean W., Mégnien, Dr. Sophie, Staels, Prof. Bart, Loomba, Prof. Rohit, Harrison, Prof. Stephen A., Ratziu, Prof. Vlad, Sanyal, Arun J., Walczak, Robert

Get full text

SAT-299-Assessment of NIS4 clinical utility for identification of patients with active NASH (NAS ≥ 4) and significant fibrosis (F ≥ 2) in patients at risk of NASH by Hanf, Remy, Chaumat, Pierre, Majd, Zouher, Cordonnier, Genevieve, Brozek, John, Praca, Emilie, Sudrik, Fouad Ben, Bedossa, Prof. Pierre, Anstee, Prof. Quentin M., Francque, Prof. Sven, Harrison, Prof. Stephen A., Ratziu, Prof. Vlad, Mégnien, Sophie, Roudot, Alice, Hosmane, Suneil, Hum, Dean W., Sanyal, Arun J.

Get full text

PS-131-Elafibranor and nitazoxanide synergize to reduce fibrosis in a NASH model by Belanger, Dr. Carole, Foucart, Dr. Corinne, Legry, Dr. Vanessa, Brozek, Mr. John, Noel, Mr. Benoit, Descamps, Ms. Emeline, Degallaix, Ms. Nathalie, Mégnien, Dr. Sophie, Hum, Dr. Dean W., Staels, Prof. Bart, Friedman, Prof. Scott L., Loomba, Prof. Rohit, Harrison, Prof. Stephen A., Walczak, Robert

Get full text